Cascade Investment
-
Ginkgo Bioworks to Go Public in a $17.5 Billion Reverse Merger With Harry Sloan's SPAC, Cathie Wood's Ark and Bill Gates' Cascade Among Investors
-
Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming
-
Ginkgo Bioworks and Soaring Eagle Acquisition (SRNG) have agreed to business combination

